Erythema Nodosum after the second dose of the Pfizer-BioNTech COVID-19 messenger RNA vaccine; a case report

Authors : Erdal BODAKÇİ

Pages : 322-323

Doi:10.48176/esmj.2022.94

View : 12 | Download : 5

Publication Date : 2022-11-30

Article Type : Other Papers

Abstract :Erythema Nodosum insert ignore into journalissuearticles values(EN); is a panniculitis characterized by acute-onset inflammation of the subcutaneous fat tissue; it can be idiopathic or associated with various clinical conditions such as infections insert ignore into journalissuearticles values(especially Beta-hemolytic streptococcal infections);, medications, pregnancy, inflammatory bowel diseases, Behçet syndrome, sarcoidosis, autoimmune diseases, and malignancies. The pathogenesis is unknown, but a delayed type IV hypersensitivity reaction to certain antigens is hypothesized [1]. EN is characterized clinically by painful tender, nodular, erythematous lesions, typically symmetrically on pretibial surfaces. The occurrence of EN after vaccination is rare and especially post-covid vaccine limited number in the literature. We describe herein, a clinical observation of EN induced by Pfizer-BioNTech COVID-19 messenger RNA vaccine.
Keywords : Eritema Nodosum, messenger RNA aşısı